CA AB922

Allows compensation for individuals providing human oocytes for medical research until January 1, 2024, with amounts to be determined by institutional review boards or human subject research panels as reasonable payment for time, discomfort, and inconvenience.

Establishes the Research Participants Undergoing Oocyte Retrieval for Medical Research Purposes Bill of Rights requiring physicians to provide written acknowledgment of specified rights and obtain both written and oral informed consent prior to oocyte retrieval procedures.

Requires institutional review boards to ensure research programs inform participants about ongoing studies assessing long-term health impacts of ovarian stimulation, provide psychological and physical screening, and cover all medical care costs resulting from the procedure.

Mandates research programs offering compensation to report aggregated deidentified data to the Legislative Analyst by January 16, 2023, including participant demographics, clinical data, and compensation amounts; requires Legislative Analyst to submit compiled report to Legislature by March 17, 2023.

Permits institutional review boards to disregard compensation amounts when oocytes from fertility patients are donated for research if specific conditions are met, including that the donor does not need the oocytes for reproductive success and the clinic is a member of the Society for Assisted Reproductive Technology.